WASHINGTON, D.C. — White House Chief of Staff Susie Wiles has been diagnosed with early-stage breast cancer and will continue in her role while undergoing treatment. Doctors have given Wiles a strong prognosis.

"Nearly one in eight women in the United States will face this diagnosis," Wiles said. "Every day, these women continue to raise their families, go to work and serve their communities with strength and determination. I now join their ranks."

President Donald Trump praised Wiles in a statement about her diagnosis. "Susie, as one of my closest and most important advisors, is tough and deeply committed to serving the American People. She will soon be better than ever!" Trump said. "During the treatment period, she will be spending virtually full time at the White House, which makes me, as President, very happy!"

"She's an amazing person and an amazing fighter, and she announced a minor difficulty which will be in good shape. She'll be around for a long time," Trump said.

White House Press Secretary Karoline Leavitt also commented on Wiles' diagnosis. "She epitomizes what it means to be a strong leader. She is also one of the nicest people I've ever met," Leavitt said.

Wiles, 68, is the first woman to serve as White House Chief of Staff. She was co-chair of Trump's 2024 campaign.

Trump credited Wiles with helping him win the 2024 and 2016 presidential elections. After the 2016 presidential election, Wiles was dispatched to help Ron DeSantis with his 2018 Florida gubernatorial campaign. After DeSantis' 2018 election win, Wiles had a falling out with him and then ran Trump's Florida campaign in 2020.

After the 2020 presidential campaign loss, Wiles ran the Save America PAC before joining the 2024 campaign as co-campaign manager. Wiles is the daughter of the late Pat Summerall, an NFL kicker and sportscaster.

The United States saw an estimated 316,000 new cases of female breast cancer in 2025, according to the National Institutes of Health. Over 300,000 women in the United States were diagnosed with breast cancer in 2025, accounting for over 15% of all cancer diagnoses that year.